The global generalized myasthenia gravis (GMG) managements market is on a strong growth trajectory, according to Future Market Insights. The market, valued at USD 1.32 billion in 2023, is expected to achieve an impressive compound annual growth rate (CAGR) of 7.6% from 2023 to 2033, reaching an estimated USD 2.96 billion by the end of …